Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
How Risky Is Too Risky?
01 Oct 2008
•
By
Michael McCaughan
Would a Big Pharma company ever sell a product like Tysabri?
More from Archive
More from Pink Sheet